BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.600
-0.030 (-1.84%)
At close: Mar 3, 2026, 4:00 PM EST
1.610
+0.010 (0.63%)
After-hours: Mar 3, 2026, 7:59 PM EST
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $34.99 million as of March 3, 2026. Its market cap has increased by 388.35% in one year.
Market Cap
34.99M
Enterprise Value
108.10M
1-Year Change
388.35%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $34.99M, a decrease of -79.72%. That is a compound annual growth rate of -18.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 34.99M | - |
| Dec 31, 2025 | 34.99M | 88.57% |
| Dec 31, 2024 | 18.56M | -78.51% |
| Dec 29, 2023 | 86.35M | -85.65% |
| Dec 30, 2022 | 601.94M | 5.82% |
| Dec 31, 2021 | 568.84M | -49.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assertio Holdings | 74.82M |
| Cumberland Pharmaceuticals | 73.59M |
| Incannex Healthcare | 50.64M |
| InterCure | 46.09M |
| Talphera | 42.49M |
| Zhengye Biotechnology Holding | 37.91M |
| Rockwell Medical | 35.49M |
| SCYNEXIS | 31.47M |